Embolotherapy Market to Grow with a CAGR of 8.35% through 2030F
Rapid technological advancement, increased prevalence of
cancer and wide acceptance of embolization procedures is expected to drive the
Global Embolotherapy Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “Embolotherapy Market - Industry
Size, Share, Trends, Opportunity, and Forecast, 2020–2030F”, the Global
Embolotherapy Market stood at USD 3.67 billion in 2024 and is anticipated to
grow with a CAGR of 8.35% in the forecast period. The embolotherapy
devices market has experienced steady growth over the past decade, fueled by
several key factors. These include a growing target patient population, rising
preference for minimally invasive procedures, increased government and private
sector investments, ongoing technological advancements in embolotherapy
devices, and supportive reimbursement policies for minimally invasive
treatments. Together, these drivers are propelling wider adoption and continued
innovation within the global embolotherapy landscape.
Cardiovascular disease (CVD) remains a major health concern
due to its high prevalence, especially among individuals aged 80 and above,
where rates exceed 20%. This drives growing demand for embolotherapy
procedures, valued for their high success rates and low postoperative
complications. Rising cases of liver cancer and hepatocellular carcinoma also
contribute to increased use of embolotherapy devices. Liver cancer is the fifth
most common cancer in men and ninth in women, with over 840,000 new global cases
in 2018 (World Cancer Research Fund). The UK has seen a 42% rise in kidney
cancer incidence over the past decade, with rates increasing by 38% in men and
44% in women.
While emerging markets and expanding clinical applications
offer significant growth potential, the market also faces challenges, including
limited clinical evidence, regulatory hurdles, and competition from alternative
therapies. Nonetheless, continued preference for minimally invasive treatments,
rising incidence of vascular diseases, and strong investment in R\&D
support the market’s positive long-term outlook.
Browse over XX market data Figures spread through XX Pages and an in-depth
TOC on "Global Embolotherapy Market”
The Global Embolotherapy Market is segmented into product, indication,
procedure, end user, regional distribution, and company.
Based on indications, The oncology segment
held the largest revenue share in 2024 and is projected to register strong CAGR
growth over the forecast period. This is primarily driven by the rising global
incidence of liver and kidney cancers and the increasing use of
chemoembolization procedures in hospitals, particularly for liver cancer
treatment. Chemoembolization is often used when conventional treatments are
unsuitable and can be combined with chemotherapy, radiation, or liver ablation.
The growing prevalence of hepatocellular carcinoma has further boosted demand
for transarterial chemoembolization (TACE) as a palliative care option,
supporting continued revenue growth in the oncology segment.
Based on region, Asia-Pacific is the fastest-growing region in the global
embolotherapy market due to a combination of demographic, economic, and
healthcare-related factors. The region is experiencing a rapid rise in the
incidence of chronic diseases such as liver cancer, kidney cancer, and
cardiovascular conditions, which significantly increases the demand for
embolotherapy procedures. Countries like China, India, and Japan have large
aging populations, who are more susceptible to such conditions, further
expanding the target patient pool. The improving healthcare infrastructure,
growing access to advanced medical technologies, and increased healthcare
spending are supporting the market’s growth. Governments and private sectors
across the region are investing heavily in modernizing hospitals and expanding
interventional radiology capabilities. The increasing awareness of minimally
invasive treatment options and a shift toward value-based healthcare are
accelerating the adoption of embolotherapy. The presence of favorable
reimbursement policies in some countries, coupled with ongoing clinical
research and local manufacturing initiatives, also boosts regional market
development. Asia-Pacific presents a fertile ground for rapid expansion in the
embolotherapy market.
Major companies operating in Global Embolotherapy Market
are:
· Medtronic,
PLC
· Microport
Scientific Corp.
· Boston
Scientific Corporation
· Stryker
Corporation
· Terumo
Corporation
· Penumbra,
Inc.
· Sirtex
(CDH)
· Johnson
& Johnson
· Abbott
Laboratories Inc.
· Balt
Group (Balt Extrusion SAS)
Customers can also request for 10% free customization
on this report.
“The global embolotherapy market is set for strong growth, driven by rising
cases of hepatic cancers, HCC, RCC, aneurysms, and varicose veins. Increasing
demand for minimally invasive procedures and higher mortality rates are key
contributors. Expanding healthcare infrastructure, greater R\&D
investments, and technological advancements further support market expansion.
The market offers diverse products like microspheres, coils, and plugs, with
chronic disease prevalence, especially cancer, continuing to fuel global demand
for embolotherapy solutions” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.
“Embolotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Embolic Agents, Microcatheters), By Indication (Oncology, Vascular, Aneurysm, Urology, Nephrology), By Procedure (TACE, TARE), By End User (Hospital, Clinics, Ambulatory Surgery Centers), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of
Global Embolotherapy Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global
Embolotherapy Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com